- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04853628
An Animation- Versus Text-based Computer-tailored Game Intervention to Prevent Alcohol Consumption in Adolescents
October 9, 2022 updated by: Marta Lima Serrano, University of Seville
ALERTA ALCOHOL: The Development and Evaluation of an Animation- Versus Text-based Computer-tailored Game Intervention to Prevent Alcohol Consumption and Binge Drinking in Adolescents
This study consists in the design, implementation and evaluation of an animation (Alerta Alcohol 2.0)- versus text-based (Alerta Alcohol) computer-tailored game intervention aimed to prevent alcohol consumption and binge drinking (BD) in Spanish adolescents.
A Cluster Randomized Controlled Trial (CRCT) is conducted to test the effectiveness of Alerta Alcohol versus Alerta Alcohol 2.0 in students aged 14 to 19 years across 24 high schools from Andalusia (southern Spain), which are randomized either to the experimental (EC-1, EC-2) or the control conditions (CC).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Alcohol use and misuse, and particularly, BD in adolescents are a highly prevalent healthcare problem that associates physical and mental health complications and community implications.
The Alerta Alcohol and Alerta Alcohol 2.0 programs are based on the I-Change Model.
A CRCT is carried out.
The schools from Andalusia are randomized either to the experimental (EC-1, EC-2) or the control conditions (CC).
The EC-1 receives an online intervention (Alerta Alcohol, which has adapted from a previous version) with personalized health advice, using textual feedback and several gamification techniques, and consists of nine sessions (performing seven of them at the high school): session 1 or baseline, sessions 2 and 3 where adolescents are provided with answers related to their views to provide highly specific feedback regarding their knowledge, risk perception, self-esteem, attitude, social influence and self-efficacy; sessions 4, 5, 7 and 8 are reinforcement sessions (booster sessions) and sessions 6 and 9 are follow-up questionnaires at six and twelve months.
The EC-2 receives an improved version of Alerta Alcohol (Alerta Alcohol 2.0) using animated videos and new gamification strategies.
The CC just completes the baseline and the evaluation questionnaires and then they are allowed to receive the intervention as well (as a waiting list).
To test the effectiveness, the primary outcome is BD within 30 days prior to evaluation and alcohol use (high-intensity drinking, weekly and any consumption) in the previous week as secondary outcomes.
Study Type
Interventional
Enrollment (Actual)
2625
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sevilla, Spain, 41009
- Marta Lima Serrano
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 19 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Students aged 14 to 19 years.
- Enrolled in Andalusian public or private high schools.
- Access to the Internet at the schools and the use of computer, mobile or tablet is allowed.
- Access to the Internet in their homes.
Exclusion Criteria:
- Language barriers.
- Previous participation in prevention programs for BD.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Alerta Alcohol
The EC-1 receives Alerta Alcohol, which consists of session 1 or baseline, two sessions in three scenarios: at home, celebrations, and public places, and two follow-up evaluations.
The adolescents are provided with answers related to their views of each scenario; this information is used to provide highly specific feedback regarding their knowledge, risk perception, self-esteem, attitude, social influence (modelling, norms and social pressure), self-efficacy and action plans.
In addition, four booster sessions are given at home to reinforce the contents of the three scenarios.
Evaluations take place after six and twelve months.
|
The intervention consists of preventive messages about the benefits of not consuming alcohol, reducing the positive attitudes and encouraging the negative attitudes towards alcohol drinking and BD, as well as social influence and self-efficacy, by personalized feedback.
Skills and action plans are encouraged to help the student to reject BD.
This information is presented through different tailored text messages.
Moreover, several gamification strategies are used (i.e. offering a challenge, giving different stories and the use of avatars in these stories that take place in three different scenarios: at home, at celebrations and in public places).
Other Names:
|
Experimental: Alerta Alcohol 2.0
The EC-2 receives an improved version of Alerta Alcohol (Alerta Alcohol 2.0) using animated videos and new gamification strategies.
Evaluations take place after six and twelve months.
|
The intervention consists of preventive messages about the benefits of not consuming alcohol, reducing the positive attitudes and encouraging the negative attitudes towards alcohol drinking and BD, as well as social influence and self-efficacy, by personalized feedback.
Skills and action plans are encouraged to help the student to reject BD.
This information is presented through different animated videos.
Moreover, new gamification strategies are added (i.e.
giving rewards and allocating points that can be accumulated and shown in a progress ranking) to those already used in Alerta Alcohol.
Other Names:
|
No Intervention: Control condition
The CC just completes the baseline and the evaluation questionnaires and then they are allowed to receive the intervention as well (as a waiting list).
Evaluations take place after six and twelve months from baseline.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change on the prevalence of binge drinking
Time Frame: 6 months after the baseline
|
Change on the prevalence of binge drinking (4/5 standard drink units or standard glasses of alcohol in one occasion for a girl/boy) within 30 days prior to evaluation.
|
6 months after the baseline
|
Change on the prevalence of binge drinking
Time Frame: 12 months after the baseline
|
Change on the prevalence of binge drinking (4/5 standard drink units or standard glasses of alcohol in one occasion for a girl/boy) within 30 days prior to evaluation.
|
12 months after the baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change on the prevalence of high-intensity drinking
Time Frame: 6 months after the baseline
|
Change on the prevalence of high-intensity drinking (8/10 standard drink units or standard glasses of alcohol in one occasion for a girl/boy) within the 7 days prior to evaluation.
|
6 months after the baseline
|
Change on the prevalence of high-intensity drinking
Time Frame: 12 months after the baseline
|
Change on the prevalence of high-intensity drinking (8/10 standard drink units or standard glasses of alcohol in one occasion for a girl/boy) within the 7 days prior to evaluation.
|
12 months after the baseline
|
Change on the average of weekly consumption
Time Frame: 6 months after the baseline
|
Change on the average of the total number of glasses consumed within the 7 days prior to evaluation.
|
6 months after the baseline
|
Change on the average of weekly consumption
Time Frame: 12 months after the baseline
|
Change on the average of the total number of glasses consumed within the 7 days prior to evaluation.
|
12 months after the baseline
|
Change on the prevalence of any consumption
Time Frame: 6 months after the baseline
|
Change on the prevalence of any consumption
|
6 months after the baseline
|
Change on the prevalence of any consumption
Time Frame: 12 months after the baseline
|
Change on the prevalence of any consumption
|
12 months after the baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2020
Primary Completion (Actual)
June 30, 2021
Study Completion (Actual)
February 28, 2022
Study Registration Dates
First Submitted
April 9, 2021
First Submitted That Met QC Criteria
April 16, 2021
First Posted (Actual)
April 21, 2021
Study Record Updates
Last Update Posted (Actual)
October 12, 2022
Last Update Submitted That Met QC Criteria
October 9, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- University of Seville (Spain)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
The IPD will be shared with other researchers through publications in scientific journals and conferences/congresses.
IPD Sharing Time Frame
From 2021.
IPD Sharing Access Criteria
The Access Criteria will be the one exposed by the scientific journals where the results of the study will be published.
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Drinking
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingDrinking Behavior | Adolescent Behavior | Drinking, Alcohol | Alcohol Drinking, AdolescentUnited States
-
University of Auckland, New ZealandTe Hiringa Hauora/Health Promotion AgencyCompletedDrinking, Alcohol | Consumption, AlcoholNew Zealand
-
Boston University Charles River CampusRecruiting
-
University of ArkansasRecruitingDrinking Behavior | Drinking Excessive | DrinkingUnited States
-
Butler HospitalNational Institute of General Medical Sciences (NIGMS)CompletedDrinking, AlcoholUnited States
-
Real Prevention, LLCCompletedUnderage Drinking | Alcohol Use, UnderageUnited States
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Active, not recruiting
-
Universidad de GranadaCompletedExercise | Drinking, AlcoholSpain
-
University of North Texas Health Science CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
University of MinnesotaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University of Michigan and other collaboratorsCompleted
Clinical Trials on Alerta Alcohol
-
University of SevilleMaastricht University; Junta de AndalucíaCompletedAlcohol Drinking | Binge Drinking | Adolescent BehaviorSpain
-
University of SevilleMaastricht University; Ministerio de Ciencia, Innovación y UniversidadesRecruitingCannabis Use | Adolescent Behavior | E-healthSpain
-
Eisai LimitedCompletedCentral Nervous SystemUnited Kingdom
-
University of Illinois at Urbana-ChampaignCarle Foundation HospitalTerminated
-
National Institute on Alcohol Abuse and Alcoholism...Recruiting
-
University of California, San FranciscoCompletedHIV Infections | Hepatitis CUnited States
-
Brown UniversityCompleted
-
Brown UniversityUnknownBinge Drinking | Sexually Transmitted Diseases | HIV/AIDS | Unsafe SexUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut de Recherches Scientifiques sur les BoissonsCompletedAlcoholic Intoxication, ChronicFrance
-
University of Illinois at Urbana-ChampaignUniversity of Missouri-Columbia; Washington University School of MedicineActive, not recruiting